| Powerful Potentials Llc | |
|
20 Sargent Rd, Brookline, NH 03033-2523 | |
| (603) 550-7002 | |
| Not Available |
| Full Name | Powerful Potentials Llc |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 20 Sargent Rd, Brookline, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831813930 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Powerful Potentials Llc Po Box 478, Brookline, NH 03033-0478 Ph: (508) 561-5471 | Powerful Potentials Llc 20 Sargent Rd, Brookline, NH 03033-2523 Ph: (603) 550-7002 |
News Archive
It's thought that antibiotic resistance is associated with a fitness cost, meaning that bacteria that develop antibiotic resistance must sacrifice something in order to do so. Because of this, proper use of antibiotics should result in susceptible strains eventually replacing resistant ones.
A compound found in the bark of the white birch tree - betulonic acid, a derivative of betulinol - may finally have been rendered a water-soluble, bio-available drug, and is already showing the potential to be a possible agent against prostate cancer - in cell culture and in an animal model.
Doctors at the Duke University School of Medicine have tested a new injectable agent that causes cancer cells in a tumor to fluoresce, potentially increasing a surgeon's ability to locate and remove all of a cancerous tumor on the first attempt. The imaging technology was developed through collaboration with scientists at Duke, the Massachusetts Institute of Technology and Lumicell Inc.
An extensive study of heart attack patients has found some patients in Australia are dying unnecessarily.
The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
› Verified 2 days ago
Mrs. Ann Marie Kline, OTD, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 20 Sargent Rd, Brookline, NH 03033 Phone: 508-561-5471 |